MktsMarkets

Standard BioTools Inc.
NASDAQ: LABKey statistics
LAB News
Stories mentioning LAB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 21,146 | 23,795 | 19,552 | 21,762 | 20,222 | 890.00 | 22,086 | 22,492 |
| Cost of Goods Sold | 9,838 | 12,413 | 10,068 | 11,134 | 9,173 | 2,695 | 9,960 | 12,118 |
| Gross Profit | 11,308 | 11,382 | 9,484 | 10,628 | 11,049 | (1,805) | 12,126 | 10,374 |
| Operating Expenses | ||||||||
| Research & Development | 2,117 | 7,969 | 6,356 | 6,222 | 5,440 | (1,332) | 6,939 | 7,244 |
| Sales General & Admin | 18,607 | 25,337 | 26,595 | 28,105 | 29,824 | 6,789 | 24,466 | 24,860 |
| Total Operating Expenses | 23,804 | 36,026 | 42,422 | 36,325 | 38,019 | 8,538 | 38,825 | 40,635 |
| Operating Income (Loss) | (12,496) | (24,644) | (32,938) | (25,697) | (26,970) | (10,343) | (26,699) | (30,261) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (5,630) | 956.00 | (2,092) | 4,963 | 567.00 | (4,143) | 957.00 | 412.00 |
| Pretax Income | (14,615) | (22,031) | (32,900) | (18,282) | (23,489) | (11,162) | (21,801) | (25,405) |
| Tax Provision | 11.00 | (35,932) | (1,216) | (609.00) | (119.00) | 257.00 | 118.00 | 39.00 |
| Net Income (Loss) | 127,068 | 19,283 | (34,687) | (33,459) | (26,033) | (34,072) | (26,938) | (45,718) |
| Earnings Per Share (Basic) | 0.33 | 0.05 | (0.09) | (0.09) | (0.07) | (0.10) | (0.07) | (0.12) |
| Earnings Per Share (Diluted) | 0.33 | 0.05 | (0.09) | (0.09) | (0.07) | (0.10) | (0.07) | (0.12) |
| Weighted Average Shares Outstanding (Basic) | 388,202 | 381,623 | 382,630 | 380,498 | 378,228 | 353,245 | 371,538 | 372,331 |
| Weighted Average Shares Outstanding (Diluted) | 388,202 | 381,623 | 382,630 | 380,498 | 378,228 | 353,245 | 371,538 | 372,331 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About LAB
Standard BioTools Inc. (NASDAQ: LAB) is a stock listed on the Nasdaq Stock Market under the ticker symbol LAB. It last traded at $0.7100 (Nov 13, 2026, 4:00 PM ET), up 8.6% on the day. That gives Standard BioTools a market capitalisation of $279.3M and a price-to-earnings ratio of 3.3.
Over the past 52 weeks LAB has traded between $0.5900 and $1.72.
Revenue for the quarter ended Mar 31, 2026 was $21.1M; net income $127.1M. Revenue was up 4.6% from $20.2M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $21.1M | $127.1M | 600.9% |
| Dec 31, 2025 | $23.8M | $19.3M | 81.0% |
| Sep 30, 2025 | $19.6M | -$34.7M | -177.4% |
| Jun 30, 2025 | $21.8M | -$33.5M | -153.7% |
From Standard BioTools’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…